AQUA: Automated Quantitative Ulcer Analysis Study

Sponsor
University of Michigan (Other)
Overall Status
Recruiting
CT.gov ID
NCT04420962
Collaborator
National Eye Institute (NEI) (NIH)
700
2
47.3
350
7.4

Study Details

Study Description

Brief Summary

This is a multiple site observational study that will review patient features (clinical and morphologic) over a 90 day period during care of participants with microbial keratitis with presence of clinically significant ≥2mm stromal infiltrate compared with participants with other forms of keratitis.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Visual Acuity

Detailed Description

The primary objective of this study is to determine associations between participant features (clinical and morphologic) and best corrected visual acuity at Day 90. Imaging, focused on slit lamp photography and supplemented by other imaging markers will be collected for review. A medical record review at one year following participants initial visit will record any corneal procedure and visual acuity testing that occurred during this window. Participants will complete demographic, clinical, and standardized health surveys.

Study Design

Study Type:
Observational
Anticipated Enrollment :
700 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Quantifying Microbial Keratitis to Predict Outcomes
Actual Study Start Date :
Jul 23, 2020
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Microbial Keratitis

Presence of a bacteria or fungal keratitis with ≥ 2mm stromal infiltrate

Diagnostic Test: Visual Acuity
Best corrected visual acuity utilizing the Snellen method

Viral or Inflammatory Keratitis

Non-infectious inflammatory, Viral, Acanthamoeba, or other forms of keratitis

Diagnostic Test: Visual Acuity
Best corrected visual acuity utilizing the Snellen method

Outcome Measures

Primary Outcome Measures

  1. Visual Acuity [90 day follow up]

    Visual Acuity

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Cases- microbial keratitis (bacterial or fungal) with presence of clinically significant ≥2mm stromal infiltrate

  • Controls- Inflammatory, viral, Acanthamoeba, or other keratitis

Exclusion Criteria:
  • Pregnancy

  • Prior incisional corneal surgery

  • No light perception vision

  • Corneal perforation or impending perforation

  • Inpatient status

  • Institutional status

  • Cognitively impaired

  • Prisoner

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan- Kellogg Eye Center Ann Arbor Michigan United States 48105
2 Aravind Eye Care System Madurai Tamil Nadu India

Sponsors and Collaborators

  • University of Michigan
  • National Eye Institute (NEI)

Investigators

  • Principal Investigator: Maria A Woodward, MD, MS, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Maria Woodward, Assistant Professor, University of Michigan
ClinicalTrials.gov Identifier:
NCT04420962
Other Study ID Numbers:
  • HUM00174923
  • R01EY031033
First Posted:
Jun 9, 2020
Last Update Posted:
Sep 14, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Maria Woodward, Assistant Professor, University of Michigan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 14, 2021